Cancer Family
Breast Neoplasm
CI-CAN-00000007Explore in graph →
Non-malignant2,895 active trials43 approved drugs310 evidence items
- NCIt
- C2910
- OncoTree
- BNNOS
- MeSH
- D000069584
- MeSH
- D001943
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000007Explore in graph →
Clinical trials
13,871 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT06865534 | Large Language Models to Aid Gynecological Oncology Treatment(EASING) | completed | N/A | 70 | Philipps University MarburgOTHER | 1 | Aug 19, 2026 | clinicaltrials |
| NCT03096054 | A Phase I Trial of LY3143921 Hydrate in Solid Tumours | completed | Phase 1 | 69 | Cancer Research UKOTHER | 1 | Aug 18, 2026 | clinicaltrials |
| NCT05162846 |
| Michigan Genetic Hereditary Testing (MiGHT)(MiGHT) |
| completed |
| N/A |
| 793 |
| University of Michigan Rogel Cancer CenterOTHER |
| 1 |
| Aug 18, 2026 |
| clinicaltrials |
| NCT06047184 | Phase I Study of BEBT-209 in Women With Advanced Breast Cancer | completed | Phase 1 | 100 | BeBetter Med IncINDUSTRY | 1 | Aug 18, 2026 | clinicaltrials |
| NCT06685796 | A Study of BEBT-209 in Combination With Chemotherapy for the Treatment of Advanced Triple-Negative Breast Cancer | completed | Phase 2 | 65 | BeBetter Med IncINDUSTRY | 1 | Aug 18, 2026 | clinicaltrials |
| NCT07440784 | Impact Of Intermittent And Water-Only Fasting On Gene Expression And Tumor Markers In Breast Cancer | completed | N/A | 60 | Khyber Medical University PeshawarOTHER | 1 | Aug 18, 2026 | clinicaltrials |
| NCT01180335 | Standard Neoadjuvant Chemotherapy Versus Genomic Driven Chemotherapy in Patients With Breast Cancer(REMAGUS04) | completed | Phase 3 | 303 | Gustave Roussy, Cancer Campus, Grand ParisOTHER | 1 | Aug 17, 2026 | clinicaltrials |
| NCT04158258 | A Study to Describe the Diagnosis, Anti-Cancer Treatment and Clinical Outcome in Patients With Newly Diagnosed Breast Cancer in Latin America | completed | — | 2,907 | Hoffmann-La RocheINDUSTRY | 10 | Aug 17, 2026 | clinicaltrials |
| NCT05193149 | Inspiratory Muscle Training in Obese Breast Cancer Survivors(IMOCS) | completed | N/A | 77 | Ohio State University Comprehensive Cancer CenterOTHER | 1 | Aug 17, 2026 | clinicaltrials |
| NCT05181722 | Evaluating the Use of Patient Navigation to Promote Timely Diagnostic Evaluation During the COVID-19 Pandemic | completed | N/A | 126 | Johns Hopkins UniversityOTHER | 1 | Aug 14, 2026 | clinicaltrials |
| NCT07760714 | A Real-World Study of Treatment Patterns, Tolerability and Effectiveness of CDK4/6 Inhibition in HR+, HER2-negative Metastatic Breast Cancer Patients | completed | — | 945 | Novartis PharmaceuticalsINDUSTRY | 1 | Aug 14, 2026 | clinicaltrials |
| NCT07764653 | Technetium Tc 99m Sulfur Colloid Injection for Tracing Sentinel Nodes in Breast Cancer | completed | Phase 3 | 213 | HTA Co., Ltd.INDUSTRY | 1 | Aug 14, 2026 | clinicaltrials |
| NCT01208974 | Nipple-Areola Complex (NAC) Irradiation After Nipple-Sparing Mastectomy and Reconstruction | completed | N/A | 21 | University of MiamiOTHER | 1 | Aug 13, 2026 | clinicaltrials |
| NCT05562518 | GRACE-trial: a Randomized Active-controlled Trial for vulvovaGinal atRophy in breAst Cancer Patients on Endocrine Therapy.(GRACE) | completed | Phase 4 | 31 | University Hospital, GhentOTHER | 1 | Aug 13, 2026 | clinicaltrials |
| NCT07160439 | Evaluating Digital Micro-Interventions to Reduce Distress and Increase Wellbeing in Breast Cancer Survivors | completed | N/A | 120 | University of VirginiaOTHER | 1 | Aug 13, 2026 | clinicaltrials |
| NCT00770809 | Paclitaxel and Trastuzumab With or Without Lapatinib in Treating Patients With Stage II or Stage III Breast Cancer That Can Be Removed by Surgery | completed | Phase 3 | 305 | National Cancer Institute (NCI)NIH | 2 | Aug 12, 2026 | clinicaltrials |
| NCT05316389 | Retrospective and Prospective Evaluation of Scapulohumeral Comfort, Aesthetic Result and Quality of Life(QUARLAMI) | completed | — | 190 | Institut Cancerologie de l'OuestOTHER | 1 | Aug 12, 2026 | clinicaltrials |
| NCT06995703 | Increasing Screening for Cancer Using EHR-Nudges Replication(I-SCREEN Rep) | completed | N/A | 8,490 | Abramson Cancer Center at Penn MedicineOTHER | 1 | Aug 12, 2026 | clinicaltrials |
| NCT07448467 | Investigation of the Effectiveness of Progressive Resistance Exercise Training in the Management of Lymphedema. | completed | N/A | 50 | Uskudar UniversityOTHER | 1 | Aug 12, 2026 | clinicaltrials |
| NCT07127315 | Gonadotropin-Releasing Hormone Agonists Benefit in Preserving the Ovarian Function in Premenopausal Breast Cancer Patients During Chemotherapy | completed | N/A | 100 | Helwan UniversityOTHER | 1 | Aug 11, 2026 | clinicaltrials |
| NCT07755553 | Effect of a Mushroom Extract-Containing Topical Cosmetic Formulation During Breast Radiotherapy | completed | N/A | 50 | Hifas da Terra S.L.INDUSTRY | 1 | Aug 10, 2026 | clinicaltrials |
| NCT02206984 | Endocrine Response in Women With Invasive Lobular Breast Cancer | completed | Phase 2 | 201 | Priscilla McAuliffeOTHER | 1 | Aug 7, 2026 | clinicaltrials |
| NCT01547741 | Docetaxel and Cyclophosphamide Compared to Anthracycline-Based Chemotherapy in Treating Women With HER2-Negative Breast Cancer | completed | Phase 3 | 4,242 | NSABP Foundation IncNETWORK | 2 | Aug 6, 2026 | clinicaltrials |
| NCT07745946 | The Effect of Virtual Reality Glasses and Breathing Exercise on Anxiety | completed | N/A | 107 | Ankara Medipol UniversityOTHER | 1 | Aug 6, 2026 | clinicaltrials |
| NCT06375707 | First-Line Ribociclib Plus Endocrine Therapy Versus Chemotherapy With or Without Subsequent Endocrine Therapy in Patients With Rapidly Progressive HR-Positive/HER2-Negative Advanced Breast Cancer | completed | Phase 2 | 74 | The First Affiliated Hospital with Nanjing Medical UniversityOTHER | 1 | Aug 5, 2026 | clinicaltrials |
| NCT05386628 | The Effect of Myofascial Chain Release Techniques on Shoulder Joint Range of Motion in Breast Cancer Survivors | completed | N/A | 36 | Istanbul Medeniyet UniversityOTHER | 1 | Aug 3, 2026 | clinicaltrials |
| NCT02654119 | Cyclophosphamide, Paclitaxel, and Trastuzumab in Treating Stage I-II HER2/Neu Positive Breast Cancer After Surgery | completed | Phase 2 | 20 | University of NebraskaOTHER | 1 | Jul 30, 2026 | clinicaltrials |
| NCT05754658 | African Cancer Genome: GMD | completed | — | 854 | Fox Chase Cancer CenterOTHER | 1 | Jul 30, 2026 | clinicaltrials |
| NCT06068257 | Tumor-Derived FGF19 | completed | — | 119 | University of Central FloridaOTHER | 1 | Jul 30, 2026 | clinicaltrials |
| NCT07040514 | 24GUT540 : Meeting of Breast Cancer Patients and Pathologists | completed | N/A | 21 | Dartmouth-Hitchcock Medical CenterOTHER | 1 | Jul 30, 2026 | clinicaltrials |
| NCT06075758 | A Study of Ribociclib in Combination With Hormonal Therapy in HR+/HER2- Advanced or Metastatic Breast Cancer | completed | — | 175 | Novartis PharmaceuticalsINDUSTRY | 3 | Jul 29, 2026 | clinicaltrials |
| NCT07590505 | Ultrahypofractionated Versus Normofractionated Sequential Boost After Whole-breast Radiation Therapy in Patients Treated With Breast-conserving Surgery for Breast Cancer(ULTIMO) | completed | Phase 3 | 132 | Cancer Research AntwerpOTHER | 1 | Jul 29, 2026 | clinicaltrials |
| NCT06604858 | Neoadjuvant Pembrolizumab and Carboplatin Plus Paclitaxel for Stage I Triple-negative Breast Cancer(TELESCOPE) | completed | Phase 2 | 31 | MedSIROTHER | 1 | Jul 27, 2026 | clinicaltrials |
| NCT02252887 | Gemcitabine, Trastuzumab, and Pertuzumab in the Treatment of Metastatic HER2-Positive Breast Cancer After Prior Trastuzumab/Pertuzumab, or Pertuzumab Based Therapy | completed | Phase 2 | 45 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jul 24, 2026 | clinicaltrials |
| NCT02876302 | Study Of Ruxolitinib (INCB018424) With Preoperative Chemotherapy For Triple Negative Inflammatory Breast Cancer | completed | Phase 2 | 23 | Dana-Farber Cancer InstituteOTHER | 1 | Jul 24, 2026 | clinicaltrials |
| NCT07040631 | Hyaluronic Acid for Prevention of Post-Intubation Sore Throat and Hoarseness | completed | N/A | 132 | Pusan National University Yangsan HospitalOTHER | 1 | Jul 24, 2026 | clinicaltrials |
| NCT07334626 | Impact of Pilates Exercises on Bone Mineral Density in Breast Cancer Survivors Receiving Hormonal Therapy(PilatesBCS2026) | completed | N/A | 60 | Benha UniversityOTHER | 1 | Jul 24, 2026 | clinicaltrials |
| NCT07724314 | Effects of a Web-Based Alopecia Education Program in Women With Breast Cancer | completed | N/A | 68 | Gulay AkmanOTHER | 1 | Jul 24, 2026 | clinicaltrials |
| NCT04553926 | 'OLAP' (OLAparib Regulatory Post-marketing Surveillance)(OLAP) | completed | — | 661 | AstraZenecaINDUSTRY | 1 | Jul 23, 2026 | clinicaltrials |
| NCT03048942 | Pilot Study of Cabazitaxel and Paclitaxel in HER2 Negative Breast Cancer(CONCEPT) | completed | Phase 2 | 158 | University Hospitals Bristol and Weston NHS Foundation TrustOTHER | 1 | Jul 21, 2026 | clinicaltrials |
| NCT03677427 | Comparing 5 and 15 Fractions for Whole Breast Irradiation After Breast Conserving Surgery(YO-HAI5) | completed | N/A | 488 | University Hospital, GhentOTHER | 1 | Jul 21, 2026 | clinicaltrials |
| NCT04537286 | First-line Nab-paclitaxel Plus Cisplatin Plus Camrelizumab in mTNBC Patients | completed | Phase 2 | 90 | Fudan UniversityOTHER | 1 | Jul 21, 2026 | clinicaltrials |
| NCT01340495 | Proton Radiation Therapy for Invasive Breast Cancer Following Mastectomy | completed | N/A | 70 | Massachusetts General HospitalOTHER | 1 | Jul 20, 2026 | clinicaltrials |
| NCT01564056 | Adjuvant Systemic Treatment for (ER)-Positive HER2-negative Breast Carcinoma in Women Over 70 According to Genomic Grade (GG): Chemotherapy + Endocrine Treatment Versus Endocrine Treatment(ASTER 70s) | completed | Phase 3 | 1,989 | UNICANCEROTHER | 2 | Jul 20, 2026 | clinicaltrials |
| NCT04758780 | Imaging Performance Assessment of 89Zi-girentuximab (89Zr-TLX250) PET in Metastatic Triple Negative Breast Cancer(OPALESCENCE) | completed | Phase 2 | 12 | Institut Cancerologie de l'OuestOTHER | 1 | Jul 20, 2026 | clinicaltrials |
| NCT07714382 | Survival Outcomes of Residual Disease in Triple-Negative Breast Cancer(ReS-TNBC) | completed | — | 100 | Sohag UniversityOTHER | 1 | Jul 20, 2026 | clinicaltrials |
| NCT03314688 | Lifestyle, Exercise, and Nutrition Study Early After Diagnosis | completed | N/A | 173 | Yale UniversityOTHER | 1 | Jul 17, 2026 | clinicaltrials |
| NCT04542135 | Sulindac and Breast Density in Women at Risk of Developing Breast Cancer | completed | Phase 2 | 61 | Alison StopeckOTHER | 1 | Jul 17, 2026 | clinicaltrials |
| NCT05634395 | Digital Phenotyping in Women Over 70 Years of Age Treated for Breast Cancer With Any Type of Treatment(GrannyFit) | completed | N/A | 200 | Institut CurieOTHER | 1 | Jul 17, 2026 | clinicaltrials |
Data updated 23 days agoSource updated Aug 19, 2026source: clinicaltrials